InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Newhall Charles W III, Director. Director active across 1 company, notably Supernus Pharmaceuticals, INC.. Aggregated, 13 reports have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €1.3m. History available since 19 February 2022. The latest transaction was disclosed on 24 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Newhall Charles W III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
4,475 股0Common StockSEC:0001005544-26-000004:0
15,000 股@ US$12.989.7% 占其流量Common StockSEC:0001628280-25-053877:0
23,800 股@ US$50.730.037% mcap50.0% 占其流量Common StockSEC:0001628280-25-044797:0
3,588 股@ US$45.018.8% 占其流量Common StockSEC:0001005544-25-000008:0
1,000 股@ US$45.002.5% 占其流量Common StockSEC:0001005544-25-000006:0
1,412 股@ US$45.003.9% 占其流量Common StockSEC:0001005544-25-000004:0
5,369 股0Common StockSEC:0001628280-25-007476:0
20,000 股@ US$9.137.1% 占其流量Common StockSEC:0001628280-24-047155:0
3,886 股0Common StockSEC:0001104659-24-028281:0
7,457 股@ US$9.242.7% 占其流量Common StockSEC:0001104659-23-119962:0
3,882 股0Common StockSEC:0001104659-23-025374:0
8,722 股@ US$7.902.7% 占其流量Common StockSEC:0001104659-22-131398:0
4,222 股0Common StockSEC:0001104659-22-026109:0
13 条申报中的 13 条
About Newhall Charles W III
Charles W. Newhall III is a Director of SUPERNUS PHARMACEUTICALS, INC. He plays a key role in the strategic direction of the company, ensuring that decisions made align with growth and innovation objectives.
